World Health Organization Recommendation for Using Uterine Balloon Tamponade to Treat Postpartum Hemorrhage.

Autor:	Weeks AD; University of Liverpool, Liverpool, United Kingdom; the Society of Gynaecology and Obstetrics in Nigeria (SOGON), Abuja, Nigeria; Instituto Paraibano de Pesquisa Professor Joaquim Amorim Neto and Instituto de Medicina Integral Professor Fernando Figueira, Paraiba, Brazil; the Division of Obstetric Anesthesia, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California; the Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and Statistics, Sorbonne, Paris, France; the Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand; the University of Calabar, Calabar, Nigeria; the Safe Motherhood Program, Department of Obstetrics, Gynecology and Reproductive Sciences, and the Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California; the Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt; the Bureau of International Health Cooperation, National Centre for Global Health and Medicine, Tokyo, Japan; and Evidence-based Healthcare and Knowledge Translation, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Akinola OI, Amorim M, Carvalho B, Deneux-Tharaux C, Liabsuetrakul T, Meremikwu M, Miller S, Nabhan A, Nagai M, Wahabi H, Walker D
Jazyk:	angličtina
Zdroj:	Obstetrics and gynecology [Obstet Gynecol] 2022 Mar 01; Vol. 139 (3), pp. 458-462.
DOI:	10.1097/AOG.0000000000004674
Abstrakt:	The World Health Organization (WHO) recently published a new recommendation on the use of the uterine balloon tamponade for the treatment of postpartum hemorrhage. The recommendation that uterine balloon tamponade should be used only where there is already access to other postpartum hemorrhage treatments (including immediate recourse to surgery) has proved controversial. It is especially problematic for those working in low-level health care facilities in under-resourced settings, where there are already programs that have introduced low-cost uterine balloon tamponade devices for use, even in settings where recourse to surgical interventions is not possible. However, there are now two separate randomized trials that both unexpectedly show unfavorable outcomes in these settings when a condom catheter uterine balloon tamponade device was introduced. Considering the balance of potential benefits and these safety concerns, the WHO postpartum hemorrhage guideline panel therefore recommends that uterine balloon tamponade should be used only in contexts where other supportive postpartum hemorrhage interventions are available if needed. Competing Interests: Financial Disclosure The authors did not report any potential conflicts of interest. (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu